Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission

• Egile Nagusiak: Thanyawee Puthanakit (Egilea), Nattawan Thepnarong (Egilea), Surasith Chaithongwongwatthana (Egilea), Suvaporn Anugulruengkitt (Egilea), Orawan Anunsittichai (Egilea), Tuangtip Theerawit (Egilea), Sasiwimol Ubolyam (Egilea), Chitsanu Pancharoen (Egilea), Praphan Phanuphak (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2018-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objectives:The rate of vertical HIV transmission for women at high risk of HIV transmission stands at approximately 7.6%. In the present study we describe infant infection rates in women who had received raltegravir (RAL) intensification during pregnancy to a standard three-drug antiretroviral (ART)...